Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gottlieb Promotes 'Bottom-Up' Review To Increase FDA Efficiency, Consistency

Executive Summary

US FDA commissioner nominee suggests breakthrough concepts should be more widely adopted within the review divisions and that staff should find and distribute best practices.


Related Content

Woodcock Wants Rapid Regulatory Policy Development
Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff
Gottlieb Q&A: Confirmation Is Nearing, Will Complete Response Letters Finally Get Released?
Complex Generics: Gottlieb Eyes FDA Policy Changes To Speed Approvals
Gottlieb's Confirmation: He's Willing To Disagree With Trump, Sec. Price
Gottlieb's FDA: Specialized Groups Could Create Review Consistency, Speed
Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI
FDA's Opioid Action Plan Could Clear Califf Nomination Roadblock
Califf Nomination Gets Fishy
“Breakthrough” Review: FDA And Sponsors Discuss Ways To Improve Efficiency





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts